Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Partilla

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|November 27, 2012
Psychoactive "bath salts": not so soothingMichael H Baumann, John S Partilla, Kurt R Lehner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2021
Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in miceGrant C Glatfelter, John S Partilla, Michael H Baumann
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine releaseRichard B Rothman, Christina M Dersch, Subramaniam Ananthan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transportersRichard B Rothman, Robert D Clark, John S Partilla, et al.
ACS Pharmacology & Translational Science|March 14, 2024
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide RevisitedGrant C Glatfelter, Eline Pottie, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 3, 2015
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrineFabio Del Bello, Farhana Sakloth, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2008
Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine releaseJoseph J Pariser, John S Partilla, Christina M Dersch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2020
Amphetamine-like Neurochemical and Cardiovascular Effects of <i>α</i>-Ethylphenethylamine Analogs Found in Dietary SupplementsCharles W Schindler, Eric B Thorndike, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2019
The Supplement Adulterant <i>β</i>-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine TransportersCharles W Schindler, Eric B Thorndike, Kenner C Rice, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2012
Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transportersRichard B Rothman, John S Partilla, Michael H Baumann, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|November 27, 2012
Psychoactive "bath salts": not so soothingMichael H Baumann, John S Partilla, Kurt R Lehner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2021
Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in miceGrant C Glatfelter, John S Partilla, Michael H Baumann
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine releaseRichard B Rothman, Christina M Dersch, Subramaniam Ananthan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transportersRichard B Rothman, Robert D Clark, John S Partilla, et al.
ACS Pharmacology & Translational Science|March 14, 2024
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide RevisitedGrant C Glatfelter, Eline Pottie, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 3, 2015
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrineFabio Del Bello, Farhana Sakloth, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2008
Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine releaseJoseph J Pariser, John S Partilla, Christina M Dersch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2020
Amphetamine-like Neurochemical and Cardiovascular Effects of <i>α</i>-Ethylphenethylamine Analogs Found in Dietary SupplementsCharles W Schindler, Eric B Thorndike, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2019
The Supplement Adulterant <i>β</i>-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine TransportersCharles W Schindler, Eric B Thorndike, Kenner C Rice, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2012
Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transportersRichard B Rothman, John S Partilla, Michael H Baumann, et al.
Pageof 7